3/13
08:00 am
edsa
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Medium
Report
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
2/15
02:08 am
edsa
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Yahoo! Finance]
Medium
Report
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Yahoo! Finance]
2/14
05:28 pm
edsa
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Canadian Business Journal (Canada)]
Medium
Report
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results [Canadian Business Journal (Canada)]
2/14
04:15 pm
edsa
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
Medium
Report
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
2/13
11:09 am
edsa
Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital [Yahoo! Finance]
Medium
Report
Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital [Yahoo! Finance]
2/13
08:11 am
edsa
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Medium
Report
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
2/13
07:00 am
edsa
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
High
Report
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules